Inventor · disambiguated record
Michael Sangi
Also filed as: SANGI MICHAEL · SANGI MICHAEL S
22 granted patents·9 pending applications·149 citations·filing 2011–2024
95Inventor score
Files withGILEAD SCIENCES INC26GILEAD PHARMASSET LLC2BABAOGLU KERIM1ORSOBIO INC1THE LIVER COMPANY INC1
Top patents by PatentIndex Score
31 records- 0195US11878965B2Inhibitors of peptidylarginine deiminasesGILEAD SCIENCES INC·Filed 2021·Granted Jan 23, 2024·4 cites·20 claims
- 0294US8809330B2Pyrazolo[1,5-A]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2013·Granted Aug 19, 2014·18 cites·10 claims
- 0394US8486938B2Pyrazolo[1,5-a]pyrimidines for antiviral treatmentBABAOGLU KERIM·Filed 2011·Granted Jul 16, 2013·25 cites·3 claims
- 0493US11976083B2Inhibitors of peptidylarginine deiminasesGILEAD SCIENCES INC·Filed 2021·Granted May 7, 2024·3 cites·15 claims
- 0593US8980878B2Compounds and methods for antiviral treatmentGILEAD SCIENCES INC·Filed 2013·Granted Mar 17, 2015·20 cites·31 claims
- 0692US9296782B2Inhibitors of hepatitis C virusGILEAD SCIENCES INC·Filed 2013·Granted Mar 29, 2016·13 cites·16 claims
- 0792US9238039B2Pyrazolo[1,5-A]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2013·Granted Jan 19, 2016·13 cites·38 claims
- 0891US9376441B2Substituted pyrrolidines as SYK inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Jun 28, 2016·17 cites·20 claims
- 0991US8946238B2Pyrazolo[1,5-A]pyrimidines as antiviral agentsGILEAD SCIENCES INC·Filed 2012·Granted Feb 3, 2015·15 cites·30 claims
- 1090US12049439B2Sulfinylaminobenzamide and sulfonylaminobenzamide derivativesORSOBIO INC·Filed 2021·Granted Jul 30, 2024·2 cites·50 claims
- 1184US11136290B2Sulfinylaminobenzamide and sulfonylaminobenzamide derivativesTHE LIVER COMPANY INC·Filed 2019·Granted Oct 5, 2021·5 cites·43 claims
- 1283US10005774B2Syk inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 26, 2018·4 cites·9 claims
- 1383US9504689B2Compounds and methods for antiviral treatmentGILEAD SCIENCES INC·Filed 2015·Granted Nov 29, 2016·3 cites·20 claims
- 1482US9655944B2Inhibitors of hepatitis C virusGILEAD SCIENCES INC·Filed 2016·Granted May 23, 2017·2 cites·2 claims
- 1581US9278975B2Pyrazolo[1,5-A]pyrimidines as antiviral agentsGILEAD SCIENCES INC·Filed 2014·Granted Mar 8, 2016·3 cites·1 claims
- 1680US10335409B2Inhibitors of hepatitis C virusGILEAD PHARMASSET LLC·Filed 2018·Granted Jul 2, 2019·1 cites·2 claims
- 1773US10603318B2Inhibitors of hepatitis C virusGILEAD PHARMASSET LLC·Filed 2019·Granted Mar 31, 2020·0 cites·2 claims
- 1867US9957275B2Pyrazolo[1,5-A]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2017·Granted May 1, 2018·0 cites·17 claims
- 1967US9440991B2Synthesis of an antiviral compoundGILEAD SCIENCES INC·Filed 2014·Granted Sep 13, 2016·1 cites·6 claims
- 2067US2025230168A1Azaspiro wrn inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2166US2018298011A1Pyrazolo[1,5-a]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 2265US2025051309A1Mk2 inhibitors and methods of making and using the sameGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2362US2017190708A1Pyrazolo[1,5-a]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 2461US2017290827A1Inhibitors of hepatitis c virusGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
- 2559US2016130275A1Pyrazolo[1,5-a]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 2658US12240862B2Inhibitors of peptidylarginine deiminasesGILEAD SCIENCES INC·Filed 2021·Granted Mar 4, 2025·0 cites·12 claims
- 2758US10174038B2Compounds and methods for antiviral treatmentGILEAD SCIENCES INC·Filed 2017·Granted Jan 8, 2019·0 cites·20 claims
- 2858US2016130300A1Inhibitors of hepatitis c virusGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 2955US2017029427A1Compounds and methods for antiviral treatmentGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 3050US2016235748A1Pyrazolo[1,5-a]pyrimidines as antiviral agentsGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 3148US10030033B2Synthesis of an antiviral compoundGILEAD SCIENCES INC·Filed 2016·Granted Jul 24, 2018·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Michael Sangi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →